Affiliation:
1. National Institute for Biological Standards and Control, Hertfordshire, England.
Abstract
An ampouled preparation of human atrial natriuretic factor, ANF-(99-126), was evaluated by 23 laboratories in 10 countries for its suitability to serve as the international standard for ANF. The preparation was calibrated by radioimmunoassay, radioreceptor binding assay, and bioassay and was shown to have satisfactory stability and biological activity. Estimates of the ANF content of a set of specimens of plasma in terms of the standard showed agreement in ranking order when the ANF was extracted prior to assay. However, estimates of the ANF content of the plasmas in terms of either the international standard or the various local standards varied widely among laboratories. On the basis of the results reported here, with the agreement of the participants in the study and with the authorization of the Expert Committee on Biological Standardization of the World Health Organization, the preparation coded 85/669 was established in 1987 as the international standard for ANF, with a defined potency of 2.5 international units per ampoule.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference8 articles.
1. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats
2. Purification and complete amino acid sequence of α-human atrial natriuretic polypeptide (α-hANP)
3. Cloning and sequence analysis of cDNA encoding a precursor for human atrial natriuretic poly peptide
4. WHO Expert Committee on Biological Standardization 29th Report. WHO Tech Rep Ser no 626 1978
5. International collaborative study of the proposed international standard for atrial natriuretic factor on behalf of the AHA/ISH/WHO: interim report, Heidelberg, September 1986;Dzau VJ;J Hypertens,1986
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献